Neurometrix Other Liabilities

Neurometrix (NURO) currently reports a other liabilities of $0 as of December 2024. That compares with $1 in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Neurometrix's other liabilities history and peer comparisons.

Neurometrix's other liabilities decreased from $1 to $0 — a 100.0% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neurometrix reported $0 in other liabilities as of December 2024. That compares with $1 in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neurometrix, and consider following NURO for alerts when major investors trade the stock.

Neurometrix is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NURO with unrelated industries.